IP Library Granted Patent US 8,338,190
Granted Patent B2
US 8,338,190 · App. 13/561,587 · Granted Dec 25, 2012

Type IV secretion system proteins in sero-detection of

Assignee: Medical Diagnostic Laboratories, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,338,190
App. No.
13/561,587
Granted
Dec 25, 2012
Kind
B2
Abstract

Disclosed are two (2) proteins in the Type IV Secretion System (TIVSS) in Anaplasma phagocytophilum (namely, virB10 and virB11) useful in the ELISA detection of Anaplasma pathogen. The recombinant expression of virB10 and virB11 and their use as kits for ELISA are also disclosed.

Claims (26)

1. A composition comprising:

(i) an isolated polypeptide, said isolated polypeptide is a recombinant polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 32 and SEQ ID NO: 33; and

(ii) a support.

2. The composition of claim 1 , wherein said support is selected from the group consisting of polyethylene, polypropylene and glass.

3. The composition of claim 1 , wherein said support is a microtiter well.

4. The composition of claim 1 , further comprising a packaging material.

5. The composition of claim 4 , wherein said packaging material comprises an instruction for detecting the presence of antibody against Anaplasma phagocytophilum.

6. The composition of claim 1 , wherein said isolated polypeptide consists of the sequence of SEQ ID NO: 32.

7. The composition of claim 6 , wherein said isolated polypeptide is produced by a method comprising the steps of:

(i) introducing an isolated polynucleotide into a host cell, said isolated polynucleotide consists of the nucleotide sequence of SEQ ID NO. 26;

(ii) growing said host cell in a culture under suitable conditions to permit production of said isolated polypeptide; and

(iii) isolating said isolated polypeptide.

8. The composition of claim 1 , wherein said isolated polypeptide consists of the sequence of SEQ ID NO: 33.

9. The composition of claim 8 , wherein said isolated polypeptide is produced by a method comprising the steps of:

(i) introducing an isolated polynucleotide into a host cell, said isolated polynucleotide consists of the nucleotide sequence of SEQ ID NO. 27;

(ii) growing said host cell in a culture under suitable conditions to permit production of said isolated polypeptide; and

(iii) isolating said isolated polypeptide.

10. The composition of claim 1 , wherein said isolated polypeptide is recombinantly expressed using an isolated polynucleotide.

11. The composition of claim 10 , wherein said isolated polynucleotide is contained within a vector.

12. The composition of claim 11 , wherein said vector is a plasmid.

13. The composition of claim 11 , wherein said vector comprises a promoter of DNA transcription operably linked to said isolated polynucleotide.

14. The composition of claim 13 , wherein said promoter is selected from the group consisting of lac promoter, trp promoter and tac promoter.

15. The composition of claim 11 , wherein said vector is transformed into a host cell.

16. The composition of claim 15 , wherein said host cell is E. coli.

17. The composition of claim 7 , wherein said growing step comprises adding glucose prior to IPTG to said culture.

18. The composition of claim 9 , wherein said growing step comprises adding glucose prior to IPTG to said culture.

Assignments (4)
SECURITY INTEREST Recorded Jul 13, 2022
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 060638/0353 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2018
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDICAL DIAGNOSTIC LABORATORIES L. L. C.
Reel/Frame 046354/0817 →
SECURITY INTEREST Recorded Apr 27, 2018
From: MEDICAL DIAGNOSTIC LABORATORIES, L.L.C.
To: TD BANK, N.A.
Reel/Frame 046031/0381 →
SECURITY INTEREST Recorded Mar 1, 2016
From: MEDICAL DIAGNOTIC LABORATORIES, L.L.C.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037963/0744 →
Continuity (3)
Division 12658268 · Feb 9, 2010
Provisional Application 61208745 · Feb 27, 2009
Related Publication 20120288882A1 · Nov 15, 2012